Global Adalimumab Biosimilar Sales Market Report 2016

November 2016 | 118 pages | ID: GC54A3C174DEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Adalimumab Biosimilar

Revenue, means the sales value of Adalimumab Biosimilar

This report studies sales (consumption) of Adalimumab Biosimilar in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• AET BioTech
• Amgen
• Boehringer Ingelheim
• Coherus Biosciences
• Fujifilm Kyowa Kirin Biologics
• LG Life Sciences/Mochida Pharmaceutical
• Momenta Pharmaceuticals
• Oncobiologics
• Pfizer
• Samsung Bioepsis
• Sandoz
• Zydus Cadila

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Adalimumab Biosimilar in these regions, from 2011 to 2021 (forecast), like

• United States
• China
• Europe
• Japan

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Adalimumab Biosimilar in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Adalimumab Biosimilar Sales Market Report 2016

1 ADALIMUMAB BIOSIMILAR OVERVIEW

1.1 Product Overview and Scope of Adalimumab Biosimilar
1.2 Classification of Adalimumab Biosimilar
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Adalimumab Biosimilar
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Adalimumab Biosimilar Market by Regions
  1.4.1 United States Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Adalimumab Biosimilar (2011-2021)
  1.5.1 Global Adalimumab Biosimilar Sales and Growth Rate (2011-2021)
  1.5.2 Global Adalimumab Biosimilar Revenue and Growth Rate (2011-2021)

2 GLOBAL ADALIMUMAB BIOSIMILAR COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Adalimumab Biosimilar Market Competition by Manufacturers
  2.1.1 Global Adalimumab Biosimilar Sales and Market Share of Key Manufacturers (2011-2016)
  2.1.2 Global Adalimumab Biosimilar Revenue and Share by Manufacturers (2011-2016)
2.2 Global Adalimumab Biosimilar (Volume and Value) by Type
  2.2.1 Global Adalimumab Biosimilar Sales and Market Share by Type (2011-2016)
  2.2.2 Global Adalimumab Biosimilar Revenue and Market Share by Type (2011-2016)
2.3 Global Adalimumab Biosimilar (Volume and Value) by Regions
  2.3.1 Global Adalimumab Biosimilar Sales and Market Share by Regions (2011-2016)
  2.3.2 Global Adalimumab Biosimilar Revenue and Market Share by Regions (2011-2016)
2.4 Global Adalimumab Biosimilar (Volume) by Application

3 UNITED STATES ADALIMUMAB BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

3.1 United States Adalimumab Biosimilar Sales and Value (2011-2016)
  3.1.1 United States Adalimumab Biosimilar Sales and Growth Rate (2011-2016)
  3.1.2 United States Adalimumab Biosimilar Revenue and Growth Rate (2011-2016)
  3.1.3 United States Adalimumab Biosimilar Sales Price Trend (2011-2016)
3.2 United States Adalimumab Biosimilar Sales and Market Share by Manufacturers
3.3 United States Adalimumab Biosimilar Sales and Market Share by Type
3.4 United States Adalimumab Biosimilar Sales and Market Share by Application

4 CHINA ADALIMUMAB BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

4.1 China Adalimumab Biosimilar Sales and Value (2011-2016)
  4.1.1 China Adalimumab Biosimilar Sales and Growth Rate (2011-2016)
  4.1.2 China Adalimumab Biosimilar Revenue and Growth Rate (2011-2016)
  4.1.3 China Adalimumab Biosimilar Sales Price Trend (2011-2016)
4.2 China Adalimumab Biosimilar Sales and Market Share by Manufacturers
4.3 China Adalimumab Biosimilar Sales and Market Share by Type
4.4 China Adalimumab Biosimilar Sales and Market Share by Application

5 EUROPE ADALIMUMAB BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Adalimumab Biosimilar Sales and Value (2011-2016)
  5.1.1 Europe Adalimumab Biosimilar Sales and Growth Rate (2011-2016)
  5.1.2 Europe Adalimumab Biosimilar Revenue and Growth Rate (2011-2016)
  5.1.3 Europe Adalimumab Biosimilar Sales Price Trend (2011-2016)
5.2 Europe Adalimumab Biosimilar Sales and Market Share by Manufacturers
5.3 Europe Adalimumab Biosimilar Sales and Market Share by Type
5.4 Europe Adalimumab Biosimilar Sales and Market Share by Application

6 JAPAN ADALIMUMAB BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Adalimumab Biosimilar Sales and Value (2011-2016)
  6.1.1 Japan Adalimumab Biosimilar Sales and Growth Rate (2011-2016)
  6.1.2 Japan Adalimumab Biosimilar Revenue and Growth Rate (2011-2016)
  6.1.3 Japan Adalimumab Biosimilar Sales Price Trend (2011-2016)
6.2 Japan Adalimumab Biosimilar Sales and Market Share by Manufacturers
6.3 Japan Adalimumab Biosimilar Sales and Market Share by Type
6.4 Japan Adalimumab Biosimilar Sales and Market Share by Application

7 GLOBAL ADALIMUMAB BIOSIMILAR MANUFACTURERS ANALYSIS

7.1 AET BioTech
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Adalimumab Biosimilar Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 AET BioTech Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
  7.1.4 Main Business/Business Overview
7.2 Amgen
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 118 Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Amgen Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
  7.2.4 Main Business/Business Overview
7.3 Boehringer Ingelheim
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 135 Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Boehringer Ingelheim Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
  7.3.4 Main Business/Business Overview
7.4 Coherus Biosciences
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Nov Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Coherus Biosciences Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
  7.4.4 Main Business/Business Overview
7.5 Fujifilm Kyowa Kirin Biologics
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
  7.5.4 Main Business/Business Overview
7.6 LG Life Sciences/Mochida Pharmaceutical
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Million USD Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
  7.6.4 Main Business/Business Overview
7.7 Momenta Pharmaceuticals
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Pharma & Healthcare Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Momenta Pharmaceuticals Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
  7.7.4 Main Business/Business Overview
7.8 Oncobiologics
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Oncobiologics Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
  7.8.4 Main Business/Business Overview
7.9 Pfizer
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Pfizer Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
  7.9.4 Main Business/Business Overview
7.10 Samsung Bioepsis
  7.10.1 Company Basic Information, Manufacturing Base and Competitors
  7.10.2 Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Samsung Bioepsis Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
  7.10.4 Main Business/Business Overview
7.11 Sandoz
7.12 Zydus Cadila

8 ADALIMUMAB BIOSIMILAR MAUFACTURING COST ANALYSIS

8.1 Adalimumab Biosimilar Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Process Analysis of Adalimumab Biosimilar

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Adalimumab Biosimilar Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Adalimumab Biosimilar Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL ADALIMUMAB BIOSIMILAR MARKET FORECAST (2016-2021)

12.1 Global Adalimumab Biosimilar Sales, Revenue Forecast (2016-2021)
12.2 Global Adalimumab Biosimilar Sales Forecast by Regions (2016-2021)
12.3 Global Adalimumab Biosimilar Sales Forecast by Type (2016-2021)
12.4 Global Adalimumab Biosimilar Sales Forecast by Application (2016-2021)

13 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Adalimumab Biosimilar
Table Classification of Adalimumab Biosimilar
Figure Global Sales Market Share of Adalimumab Biosimilar by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Adalimumab Biosimilar
Figure Global Sales Market Share of Adalimumab Biosimilar by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure United States Adalimumab Biosimilar Revenue and Growth Rate (2011-2021)
Figure China Adalimumab Biosimilar Revenue and Growth Rate (2011-2021)
Figure Europe Adalimumab Biosimilar Revenue and Growth Rate (2011-2021)
Figure Japan Adalimumab Biosimilar Revenue and Growth Rate (2011-2021)
Figure Global Adalimumab Biosimilar Sales and Growth Rate (2011-2021)
Figure Global Adalimumab Biosimilar Revenue and Growth Rate (2011-2021)
Table Global Adalimumab Biosimilar Sales of Key Manufacturers (2011-2016)
Table Global Adalimumab Biosimilar Sales Share by Manufacturers (2011-2016)
Figure 2015 Adalimumab Biosimilar Sales Share by Manufacturers
Figure 2016 Adalimumab Biosimilar Sales Share by Manufacturers
Table Global Adalimumab Biosimilar Revenue by Manufacturers (2011-2016)
Table Global Adalimumab Biosimilar Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Adalimumab Biosimilar Revenue Share by Manufacturers
Table 2016 Global Adalimumab Biosimilar Revenue Share by Manufacturers
Table Global Adalimumab Biosimilar Sales and Market Share by Type (2011-2016)
Table Global Adalimumab Biosimilar Sales Share by Type (2011-2016)
Figure Sales Market Share of Adalimumab Biosimilar by Type (2011-2016)
Figure Global Adalimumab Biosimilar Sales Growth Rate by Type (2011-2016)
Table Global Adalimumab Biosimilar Revenue and Market Share by Type (2011-2016)
Table Global Adalimumab Biosimilar Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Adalimumab Biosimilar by Type (2011-2016)
Figure Global Adalimumab Biosimilar Revenue Growth Rate by Type (2011-2016)
Table Global Adalimumab Biosimilar Sales and Market Share by Regions (2011-2016)
Table Global Adalimumab Biosimilar Sales Share by Regions (2011-2016)
Figure Sales Market Share of Adalimumab Biosimilar by Regions (2011-2016)
Figure Global Adalimumab Biosimilar Sales Growth Rate by Regions (2011-2016)
Table Global Adalimumab Biosimilar Revenue and Market Share by Regions (2011-2016)
Table Global Adalimumab Biosimilar Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Adalimumab Biosimilar by Regions (2011-2016)
Figure Global Adalimumab Biosimilar Revenue Growth Rate by Regions (2011-2016)
Table Global Adalimumab Biosimilar Sales and Market Share by Application (2011-2016)
Table Global Adalimumab Biosimilar Sales Share by Application (2011-2016)
Figure Sales Market Share of Adalimumab Biosimilar by Application (2011-2016)
Figure Global Adalimumab Biosimilar Sales Growth Rate by Application (2011-2016)
Figure United States Adalimumab Biosimilar Sales and Growth Rate (2011-2016)
Figure United States Adalimumab Biosimilar Revenue and Growth Rate (2011-2016)
Figure United States Adalimumab Biosimilar Sales Price Trend (2011-2016)
Table United States Adalimumab Biosimilar Sales by Manufacturers (2011-2016)
Table United States Adalimumab Biosimilar Market Share by Manufacturers (2011-2016)
Table United States Adalimumab Biosimilar Sales by Type (2011-2016)
Table United States Adalimumab Biosimilar Market Share by Type (2011-2016)
Table United States Adalimumab Biosimilar Sales by Application (2011-2016)
Table United States Adalimumab Biosimilar Market Share by Application (2011-2016)
Figure China Adalimumab Biosimilar Sales and Growth Rate (2011-2016)
Figure China Adalimumab Biosimilar Revenue and Growth Rate (2011-2016)
Figure China Adalimumab Biosimilar Sales Price Trend (2011-2016)
Table China Adalimumab Biosimilar Sales by Manufacturers (2011-2016)
Table China Adalimumab Biosimilar Market Share by Manufacturers (2011-2016)
Table China Adalimumab Biosimilar Sales by Type (2011-2016)
Table China Adalimumab Biosimilar Market Share by Type (2011-2016)
Table China Adalimumab Biosimilar Sales by Application (2011-2016)
Table China Adalimumab Biosimilar Market Share by Application (2011-2016)
Figure Europe Adalimumab Biosimilar Sales and Growth Rate (2011-2016)
Figure Europe Adalimumab Biosimilar Revenue and Growth Rate (2011-2016)
Figure Europe Adalimumab Biosimilar Sales Price Trend (2011-2016)
Table Europe Adalimumab Biosimilar Sales by Manufacturers (2011-2016)
Table Europe Adalimumab Biosimilar Market Share by Manufacturers (2011-2016)
Table Europe Adalimumab Biosimilar Sales by Type (2011-2016)
Table Europe Adalimumab Biosimilar Market Share by Type (2011-2016)
Table Europe Adalimumab Biosimilar Sales by Application (2011-2016)
Table Europe Adalimumab Biosimilar Market Share by Application (2011-2016)
Figure Japan Adalimumab Biosimilar Sales and Growth Rate (2011-2016)
Figure Japan Adalimumab Biosimilar Revenue and Growth Rate (2011-2016)
Figure Japan Adalimumab Biosimilar Sales Price Trend (2011-2016)
Table Japan Adalimumab Biosimilar Sales by Manufacturers (2011-2016)
Table Japan Adalimumab Biosimilar Market Share by Manufacturers (2011-2016)
Table Japan Adalimumab Biosimilar Sales by Type (2011-2016)
Table Japan Adalimumab Biosimilar Market Share by Type (2011-2016)
Table Japan Adalimumab Biosimilar Sales by Application (2011-2016)
Table Japan Adalimumab Biosimilar Market Share by Application (2011-2016)
Table AET BioTech Basic Information List
Table AET BioTech Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Figure AET BioTech Adalimumab Biosimilar Global Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Adalimumab Biosimilar Global Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Boehringer Ingelheim Adalimumab Biosimilar Global Market Share (2011-2016)
Table Coherus Biosciences Basic Information List
Table Coherus Biosciences Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Coherus Biosciences Adalimumab Biosimilar Global Market Share (2011-2016)
Table Fujifilm Kyowa Kirin Biologics Basic Information List
Table Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Global Market Share (2011-2016)
Table LG Life Sciences/Mochida Pharmaceutical Basic Information List
Table LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Figure LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Global Market Share (2011-2016)
Table Momenta Pharmaceuticals Basic Information List
Table Momenta Pharmaceuticals Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Momenta Pharmaceuticals Adalimumab Biosimilar Global Market Share (2011-2016)
Table Oncobiologics Basic Information List
Table Oncobiologics Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Oncobiologics Adalimumab Biosimilar Global Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Adalimumab Biosimilar Global Market Share (2011-2016)
Table Samsung Bioepsis Basic Information List
Table Samsung Bioepsis Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Samsung Bioepsis Adalimumab Biosimilar Global Market Share (2011-2016)
Table Sandoz Basic Information List
Table Sandoz Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sandoz Adalimumab Biosimilar Global Market Share (2011-2016)
Table Zydus Cadila Basic Information List
Table Zydus Cadila Adalimumab Biosimilar Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Zydus Cadila Adalimumab Biosimilar Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Adalimumab Biosimilar
Figure Manufacturing Process Analysis of Adalimumab Biosimilar
Figure Adalimumab Biosimilar Industrial Chain Analysis
Table Raw Materials Sources of Adalimumab Biosimilar Major Manufacturers in 2015
Table Major Buyers of Adalimumab Biosimilar
Table Distributors/Traders List
Figure Global Adalimumab Biosimilar Sales and Growth Rate Forecast (2016-2021)
Figure Global Adalimumab Biosimilar Revenue and Growth Rate Forecast (2016-2021)
Table Global Adalimumab Biosimilar Sales Forecast by Regions (2016-2021)
Table Global Adalimumab Biosimilar Sales Forecast by Type (2016-2021)
Table Global Adalimumab Biosimilar Sales Forecast by Application (2016-2021)